Regulatory Industry Survey

Research

Regulatory Industry Survey

Survey Reveals Unsustainable Regulatory Workloads, Highlighting AI as a Critical Solution

Independent research confirms that regulatory teams in life sciences are facing unprecedented challenges, with workloads increasing faster than companies can handle. A staggering 96% of regulatory professionals believe that AI is essential to managing this burden, yet barriers like outdated IT systems are slowing adoption.

"*" indicates required fields

First Name*

Last Name*

Email*

Company Name*

This field is hidden when viewing the form

Job Title*

This field is hidden when viewing the form

HQ Country*

This field is hidden when viewing the form

Area of Interest*

Phone

This field is for validation purposes and should be left unchanged.

AI: The Future of Regulatory Affairs

With a growing consensus on the importance of AI, the survey reveals that next-generation technologies such as Generative AI and machine learning will be crucial in transforming regulatory workflows, improving accuracy, and cutting costs.

Download the full report to explore how industry leaders are preparing for AI adoption and discover practical steps for overcoming barriers today.

LifeSphere® Technology is trusted by these industry leaders:

Mladen Prenc2024-11-08T14:48:26+00:00

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us

Research